Literature DB >> 26521271

Weaning from inhaled corticosteroids in COPD: the evidence.

Samy Suissa1, Andrea Rossi2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26521271     DOI: 10.1183/13993003.00282-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.

Authors:  Jennifer K Quint; Jukka Montonen; Daina B Esposito; Xintong He; Leslie Koerner; Laura Wallace; Alberto de la Hoz; Marc Miravitlles
Journal:  Adv Ther       Date:  2021-03-15       Impact factor: 3.845

Review 2.  The dose of inhaled corticosteroids in patients with COPD: when less is better.

Authors:  José Luis Izquierdo; Borja G Cosio
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-25

3.  Toward effective prescription of inhaled corticosteroids in chronic airway disease.

Authors:  Zuzana Diamant; Guy Brusselle; Richard E Russell
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-18

Review 4.  Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal.

Authors:  Barbara P Yawn; Samy Suissa; Andrea Rossi
Journal:  NPJ Prim Care Respir Med       Date:  2016-09-29       Impact factor: 2.871

5.  Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?

Authors:  Samy Suissa
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.